Multinational Ambispective Study of the Clinical Management and Burden of Bipolar Disorder (WAVE bd Study).

Trial Profile

Multinational Ambispective Study of the Clinical Management and Burden of Bipolar Disorder (WAVE bd Study).

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 May 2012

At a glance

  • Drugs Neuropsychotherapeutics; Quetiapine
  • Indications Bipolar I disorders; Bipolar II disorders
  • Focus Therapeutic Use
  • Acronyms WAVE bd
  • Sponsors AstraZeneca
  • Most Recent Events

    • 22 May 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 22 May 2012 Additional trial location (Ukraine) identified as reported by ClinicalTrials.gov.
    • 15 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top